Tapewire

NYSE · USD

CVS

CVS HEALTH Corp

Export transactions ↓
Tapewire entity
2884
SEC CIK
0000064803
Parsed reports
1,748

Last 12 months

Inside the activity.

0 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202608
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 28, 2018 Filed Nov 30, 2018 22:34 UTC GrantCommon Stock 1,378 $80.27 $110,612.06
Disclosure

SEC source: 0001127602-18-034860 · form4.xml · nonDerivative · entry 2

LUDWIG EDWARD J · CIK 0001221783 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,457

F2 · shares: Consists of common stock issued as a pro rata portion of the retainer payable for the reporting person's 2018-2019 Board service, pursuant to the Registrant's 2017 Incentive Compensation Plan.

Read SEC document
November 28, 2018 Filed Nov 30, 2018 22:34 UTC GrantCommon Stock 11,079 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-18-034860 · form4.xml · nonDerivative · entry 1

LUDWIG EDWARD J · CIK 0001221783 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,079

F1 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share.

Read SEC document
November 14, 2018 Filed Nov 16, 2018 21:19 UTC
Brennan Troyen AEVP and Chief Medical Officer
SaleCommon Stock 14,229 $82.00 $1,166,778.00
Disclosure

SEC source: 0001127602-18-033414 · form4.xml · nonDerivative · entry 1

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,494.059

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:43 UTC GrantCommon Stock 1,404 $78.77 $110,593.08
Disclosure

SEC source: 0001127602-18-032655 · form4.xml · nonDerivative · entry 1

BRACKEN RICHARD M · CIK 0001216830 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,392

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:44 UTC GrantShare Credits · Derivative 1,904.2783 $78.77 Strike: $0.00 $150,000.00
Disclosure

SEC source: 0001127602-18-032657 · form4.xml · derivative · entry 2

BROWN C DAVID II · CIK 0001197672 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,106.8166

Underlying: Common Stock · 1,904.2783 shares

Expires not disclosed

F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:45 UTC GrantCommon Stock 1,332 $78.77 $104,921.64
Disclosure

SEC source: 0001127602-18-032658 · form4.xml · nonDerivative · entry 1

DECOUDREAUX ALECIA A · CIK 0001233354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,970

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:46 UTC GrantCommon Stock 1,332 $78.77 $104,921.64
Disclosure

SEC source: 0001127602-18-032659 · form4.xml · nonDerivative · entry 1

DEPARLE NANCY ANN · CIK 0001144511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,383

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:47 UTC GrantCommon Stock 3,618 $78.77 $284,989.86
Disclosure

SEC source: 0001127602-18-032660 · form4.xml · nonDerivative · entry 1

DORMAN DAVID W · CIK 0001082870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,702

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:47 UTC GrantCommon Stock 1,332 $78.77 $104,921.64
Disclosure

SEC source: 0001127602-18-032661 · form4.xml · nonDerivative · entry 1

Finucane Anne A. · CIK 0001511491 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,332

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:48 UTC GrantCommon Stock 1,332 $78.77 $104,921.64
Disclosure

SEC source: 0001127602-18-032662 · form4.xml · nonDerivative · entry 1

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,332

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:49 UTC GrantShare Credits · Derivative 1,777.3264 $78.77 Strike: $0.00 $140,000.00
Disclosure

SEC source: 0001127602-18-032664 · form4.xml · derivative · entry 1

SCHAPIRO MARY L · CIK 0001192486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,887.0105

Underlying: Common Stock · 1,777.3264 shares

Expires not disclosed

F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:50 UTC GrantShare Credits · Derivative 1,452.0122 $78.77 Strike: $0.00 $114,375.00
Disclosure

SEC source: 0001127602-18-032666 · form4.xml · derivative · entry 2

SWIFT RICHARD J · CIK 0001200537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,371.0817

Underlying: Common Stock · 1,452.0122 shares

Expires not disclosed

F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:51 UTC GrantShare Credits · Derivative 1,777.3264 $78.77 Strike: $0.00 $140,000.00
Disclosure

SEC source: 0001127602-18-032668 · form4.xml · derivative · entry 2

WELDON WILLIAM C · CIK 0001189019 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,524.6414

Underlying: Common Stock · 1,777.3264 shares

Expires not disclosed

F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

Read SEC document
November 07, 2018 Filed Nov 9, 2018 21:52 UTC
WHITE TONY LDirector
GrantCommon Stock 1,332 $78.77 $104,921.64
Disclosure

SEC source: 0001127602-18-032671 · form4.xml · nonDerivative · entry 1

WHITE TONY L · CIK 0001171315 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,490

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:07 UTC
Bisaccia LisaEVP and Chief HR Officer
Exercise / conversionStock Option · Derivative 13,770 $0.00 Strike: $54.53 $0.00
Disclosure

SEC source: 0001127602-18-029360 · form4.xml · derivative · entry 9

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,770 shares

Expires 2020-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:07 UTC
Bisaccia LisaEVP and Chief HR Officer
Exercise / conversionStock Option · Derivative 7,764 $0.00 Strike: $45.07 $0.00
Disclosure

SEC source: 0001127602-18-029360 · form4.xml · derivative · entry 8

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,764 shares

Expires 2019-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:07 UTC
Bisaccia LisaEVP and Chief HR Officer
SaleCommon Stock 13,770 $80.00 $1,101,600.00
Disclosure

SEC source: 0001127602-18-029360 · form4.xml · nonDerivative · entry 4

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,086

F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:07 UTC
Bisaccia LisaEVP and Chief HR Officer
Exercise / conversionCommon Stock 13,770 $54.53 $750,878.10
Disclosure

SEC source: 0001127602-18-029360 · form4.xml · nonDerivative · entry 3

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:07 UTC
Bisaccia LisaEVP and Chief HR Officer
SaleCommon Stock 7,764 $80.00 $621,120.00
Disclosure

SEC source: 0001127602-18-029360 · form4.xml · nonDerivative · entry 2

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,086

F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:07 UTC
Bisaccia LisaEVP and Chief HR Officer
Exercise / conversionCommon Stock 7,764 $45.07 $349,923.48
Disclosure

SEC source: 0001127602-18-029360 · form4.xml · nonDerivative · entry 1

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:09 UTC
Boratto Eva CEVP, Cont & Chief Acct Officer
Exercise / conversionStock Option · Derivative 4,426 $0.00 Strike: $54.53 $0.00
Disclosure

SEC source: 0001127602-18-029362 · form4.xml · derivative · entry 4

Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,852

Underlying: Common Stock · 4,426 shares

Expires 2020-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:09 UTC
Boratto Eva CEVP, Cont & Chief Acct Officer
SaleCommon Stock 4,426 $80.00 $354,080.00
Disclosure

SEC source: 0001127602-18-029362 · form4.xml · nonDerivative · entry 2

Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,850.9749

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:09 UTC
Boratto Eva CEVP, Cont & Chief Acct Officer
Exercise / conversionCommon Stock 4,426 $54.53 $241,349.78
Disclosure

SEC source: 0001127602-18-029362 · form4.xml · nonDerivative · entry 1

Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,276.9749

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 17, 2018 Filed Sep 19, 2018 20:26 UTC
Boratto Eva CEVP, Cont & Chief Acct Officer
Exercise / conversionStock Option · Derivative 13,311 $0.00 Strike: $45.07 $0.00
Disclosure

SEC source: 0001127602-18-028061 · form4.xml · derivative · entry 3

Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,311 shares

Expires 2019-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013.

Read SEC document
September 17, 2018 Filed Sep 19, 2018 20:26 UTC
Boratto Eva CEVP, Cont & Chief Acct Officer
SaleCommon Stock 13,311 $77.16 $1,027,076.76
Disclosure

SEC source: 0001127602-18-028061 · form4.xml · nonDerivative · entry 2

Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,850.9749

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $76.77 and $77.93 per share.

Read SEC document
September 17, 2018 Filed Sep 19, 2018 20:26 UTC
Boratto Eva CEVP, Cont & Chief Acct Officer
Exercise / conversionCommon Stock 13,311 $45.07 $599,926.77
Disclosure

SEC source: 0001127602-18-028061 · form4.xml · nonDerivative · entry 1

Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,161.9749

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 20:37 UTC
Hourican KevinEVP & President, CVS Pharmacy
Exercise / conversionStock Option · Derivative 4,426 $0.00 Strike: $54.53 $0.00
Disclosure

SEC source: 0001127602-18-026463 · form4.xml · derivative · entry 4

Hourican Kevin · CIK 0001741853 · EVP & President, CVS Pharmacy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,426 shares

Expires 2020-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option became exercisable in four equal annual installments beginning on 4/1/2014.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 20:37 UTC
Hourican KevinEVP & President, CVS Pharmacy
SaleCommon Stock 8,564 $75.00 $642,300.00
Disclosure

SEC source: 0001127602-18-026463 · form4.xml · nonDerivative · entry 2

Hourican Kevin · CIK 0001741853 · EVP & President, CVS Pharmacy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,571

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 20:37 UTC
Hourican KevinEVP & President, CVS Pharmacy
Exercise / conversionCommon Stock 4,426 $54.53 $241,349.78
Disclosure

SEC source: 0001127602-18-026463 · form4.xml · nonDerivative · entry 1

Hourican Kevin · CIK 0001741853 · EVP & President, CVS Pharmacy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,135

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:13 UTC GrantShare Credits · Derivative 2,340.0936 $64.10 Strike: $0.00 $150,000.00
Disclosure

SEC source: 0001127602-18-020147 · form4.xml · derivative · entry 1

BROWN C DAVID II · CIK 0001197672 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,380.8728

Underlying: Common Stock · 2,340.0936 shares

Expires not disclosed

F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:14 UTC GrantShare Credits · Derivative 2,184.0874 $64.10 Strike: $0.00 $140,000.00
Disclosure

SEC source: 0001127602-18-020148 · form4.xml · derivative · entry 1

SCHAPIRO MARY L · CIK 0001192486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,021.9237

Underlying: Common Stock · 2,184.0874 shares

Expires not disclosed

F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:16 UTC GrantShare Credits · Derivative 1,784.3214 $64.10 Strike: $0.00 $114,375.00
Disclosure

SEC source: 0001127602-18-020150 · form4.xml · derivative · entry 1

SWIFT RICHARD J · CIK 0001200537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,044.0189

Underlying: Common Stock · 1,784.3214 shares

Expires not disclosed

F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:18 UTC GrantShare Credits · Derivative 2,184.0874 $64.10 Strike: $0.00 $140,000.00
Disclosure

SEC source: 0001127602-18-020152 · form4.xml · derivative · entry 1

WELDON WILLIAM C · CIK 0001189019 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,463.6615

Underlying: Common Stock · 2,184.0874 shares

Expires not disclosed

F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:19 UTC GrantCommon Stock 1,725 $64.10 $110,572.50
Disclosure

SEC source: 0001127602-18-020153 · form4.xml · nonDerivative · entry 1

BRACKEN RICHARD M · CIK 0001216830 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,988

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:21 UTC GrantCommon Stock 1,638 $64.10 $104,995.80
Disclosure

SEC source: 0001127602-18-020154 · form4.xml · nonDerivative · entry 1

DECOUDREAUX ALECIA A · CIK 0001233354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,638

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:23 UTC GrantCommon Stock 1,638 $64.10 $104,995.80
Disclosure

SEC source: 0001127602-18-020155 · form4.xml · nonDerivative · entry 1

DEPARLE NANCY ANN · CIK 0001144511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,051

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:25 UTC GrantCommon Stock 4,446 $64.10 $284,988.60
Disclosure

SEC source: 0001127602-18-020156 · form4.xml · nonDerivative · entry 1

DORMAN DAVID W · CIK 0001082870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,084

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:27 UTC GrantCommon Stock 1,638 $64.10 $104,995.80
Disclosure

SEC source: 0001127602-18-020158 · form4.xml · nonDerivative · entry 1

Finucane Anne A. · CIK 0001511491 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,638

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:29 UTC GrantCommon Stock 1,638 $64.10 $104,995.80
Disclosure

SEC source: 0001127602-18-020159 · form4.xml · nonDerivative · entry 1

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,638

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
June 04, 2018 Filed Jun 7, 2018 13:34 UTC
WHITE TONY LDirector
GrantCommon Stock 1,638 $64.10 $104,995.80
Disclosure

SEC source: 0001127602-18-020286 · form4.xml · nonDerivative · entry 1

WHITE TONY L · CIK 0001171315 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,158

F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

Read SEC document
May 04, 2018 Filed May 7, 2018 14:17 UTC PurchaseCommon Stock 10,000 $61.99 $619,900.00
Disclosure

SEC source: 0001127602-18-016443 · form4.xml · nonDerivative · entry 1

BROWN C DAVID II · CIK 0001197672 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,252

Read SEC document
May 04, 2018 Filed May 7, 2018 14:20 UTC PurchaseCommon Stock 24,300 $62.22 $1,511,868.24
Disclosure

SEC source: 0001127602-18-016444 · form4.xml · nonDerivative · entry 1

DORMAN DAVID W · CIK 0001082870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,638

F1 · price: Represents weighted average purchase price for this group of purchases, which occurred on the same day. Multiple purchases were conducted, ranging between $62.03 and $62.36 per share.

Read SEC document
April 01, 2018 Filed Apr 3, 2018 21:13 UTC
MERLO LARRY JDirector · President and CEO
GrantStock Option · Derivative 394,091 $62.21 Strike: $62.21 $24,516,401.11
Disclosure

SEC source: 0001127602-18-013795 · form4.xml · derivative · entry 6

MERLO LARRY J · CIK 0001194413 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 394,091

Underlying: Common Stock · 394,091 shares

Expires 2025-04-01

F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

Read SEC document
April 01, 2018 Filed Apr 3, 2018 21:13 UTC
MERLO LARRY JDirector · President and CEO
Tax withholdingCommon Stock 25,498 $62.21 $1,586,230.58
Disclosure

SEC source: 0001127602-18-013795 · form4.xml · nonDerivative · entry 1

MERLO LARRY J · CIK 0001194413 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 330,107.4096

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan.

Read SEC document
April 01, 2018 Filed Apr 3, 2018 21:19 UTC
Denton David MEVP and CFO
GrantStock Option · Derivative 116,767 $62.21 Strike: $62.21 $7,264,075.07
Disclosure

SEC source: 0001127602-18-013809 · form4.xml · derivative · entry 4

Denton David M · CIK 0001428718 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,767

Underlying: Common Stock · 116,767 shares

Expires 2025-04-01

F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

Read SEC document
April 01, 2018 Filed Apr 3, 2018 21:19 UTC
Denton David MEVP and CFO
Tax withholdingCommon Stock 4,351 $62.21 $270,675.71
Disclosure

SEC source: 0001127602-18-013809 · form4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,494.99

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan.

Read SEC document
April 01, 2018 Filed Apr 3, 2018 21:16 UTC
Roberts Jonathan CEVP & Chief Operating Officer
GrantStock Option · Derivative 248,131 $62.21 Strike: $62.21 $15,436,229.51
Disclosure

SEC source: 0001127602-18-013801 · form4.xml · derivative · entry 5

Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,131

Underlying: Common Stock · 248,131 shares

Expires 2025-04-01

F1 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

Read SEC document
April 01, 2018 Filed Apr 3, 2018 21:23 UTC
Moriarty Thomas MEVP & General Counsel
GrantStock Option · Derivative 145,959 $62.21 Strike: $62.21 $9,080,109.39
Disclosure

SEC source: 0001127602-18-013814 · form4.xml · derivative · entry 4

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,959

Underlying: Common Stock · 145,959 shares

Expires 2025-04-01

F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

Read SEC document
April 01, 2018 Filed Apr 3, 2018 21:23 UTC
Moriarty Thomas MEVP & General Counsel
Tax withholdingCommon Stock 4,629 $62.21 $287,970.09
Disclosure

SEC source: 0001127602-18-013814 · form4.xml · nonDerivative · entry 1

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,408.8884

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan.

Read SEC document
April 01, 2018 Filed Apr 3, 2018 21:26 UTC
Bisaccia LisaEVP and Chief HR Officer
GrantStock Option · Derivative 64,222 $62.21 Strike: $62.21 $3,995,250.62
Disclosure

SEC source: 0001127602-18-013817 · form4.xml · derivative · entry 5

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,222

Underlying: Common Stock · 64,222 shares

Expires 2025-04-01

F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.